Dow Down0.62% Nasdaq Down1.14%

Nu Skin Enterprises Inc. (NUS)

42.19 Down 1.08(2.50%) Sep 22, 4:01PM EDT
|After Hours : 42.10 Down 0.09 (0.21%) Sep 22, 5:32PM EDT
ProfileGet Profile for:
Nu Skin Enterprises Inc.
75 West Center Street
Provo, UT 84601
United States - Map
Phone: 801-345-1000

Index Membership:N/A
Sector:Consumer Goods
Industry:Personal Products
Full Time Employees:5,056

Business Summary 

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands. It offers skin-care systems and treatment products, including ageLOC Galvanic Spa System, ageLOC Galvanic Body Spa, and ageLOC Transformation anti-aging skin care system, as well as other cosmetic, personal, and hair care products. The company also provides ageLOC TR90 weight management and body shaping systems; LifePak; ageLOC R2 nutritional supplement; and ageLOC transformation daily skin care system. It is involved in the research and product development of aging, including the influence of certain ingredients on gene expression. The company sells its products directly, as well as through its retail stores and Website in Mainland China. Nu Skin Enterprises distributes its products in Greater China, North Asia, the South Asia/Pacific, and the Americas, as well as Europe, the Middle East, and Africa. The company was founded in 1984 and is headquartered in Provo, Utah.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Nu Skin Enterprises Inc.

Corporate Governance 
Nu Skin Enterprises Inc.’s ISS Governance QuickScore as of Sep 1, 2014 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 6; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Steven J. Lund , 61
Exec. Chairman
Mr. M. Truman Hunt , 55
Chief Exec. Officer, Pres and Director
Mr. Ritch N. Wood , 48
Chief Financial Officer, Principal Accounting Officer and VP
Mr. Daniel R. Chard , 49
Pres of Global Sales and Operations
Dr. Joseph Y. Chang Ph.D., 61
Chief Scientific Officer and Exec. VP of Product Devel.
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders